Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,972,950 papers from all fields of science
Search
Sign In
Create Free Account
latanoprost / Timolol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Timolol
latanoprost
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Current Preferred Agents: BETAXOLOL, BRIMONIDINE (ALPHAGAN AND ALPHAGAN P), BRINZOLAMIDE (AZOPT), CARTEOLOL. DORZOLAMIDE/TIMOLOL, LATANOPROST, PILOCARPINE GEL AND DROPS, and TRAVOPROST (TRAVATAN Z…
2014
Corpus ID: 16986178
Background: The first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed-combination…
Expand
2013
2013
Efficacy and safety of pneumatic trabeculoplasty versus timolol added to latanoprost in primary open angle glaucoma.
M. Kocabora
,
M. Ozsutçu
,
N. Kandemir
,
E. Gocmez
,
K. Fazıl
,
G. Gulkilik
Clinica Terapeutica
2013
Corpus ID: 32294349
BACKGROUND To compare the safety and short-term additive hypotensive effect of pneumatic trabeculoplasty (PNT) versus timolol…
Expand
2012
2012
A 6-Month, Observational Trial Investigating with Electronic Monitoring the Level of Adherence and Ocular Surface Health with Latanoprost/Timolol Fixed Versus Latanoprost and Timolol Unfixed Therapy…
K. Boboridis
,
A. Konstas
,
+7 authors
M. Kahook
2012
Corpus ID: 73569605
A 6-month, observational trial investigating with electronic monitoring the level of adherence and ocular surface health with…
Expand
Review
2008
Review
2008
[Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma].
A. Martínez
,
John Slof
Archivos de la Sociedad Española de Oftalmología
2008
Corpus ID: 24732395
OBJECTIVE To assess the cost-efficacy of three fixed-combination glaucoma treatments currently available in Spain [bimatoprost…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required